Core Laboratories NV Strategic Asset Allocation Index
Core Laboratories NV strategic asset allocation index. Core Laboratories NV (CLB) has a Strategic Asset Allocation Index of 56.6% as of December 2025. Strategic assets (PP&E of $153.79 Million plus long-term investments of $4.43 Million) total $158.22 Million, measured against net assets of $279.76 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Core Laboratories NV (CLB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Core Laboratories NV (2000–2025)
Strategic asset allocation index of Core Laboratories NV from 2000 to 2025. This chart shows how Core Laboratories NV's Strategic Asset Allocation Index has evolved across 25 annual periods from 2000 to 2025. As of December 2025, the index stands at 56.6%, representing strategic assets of $158.22 Million against net assets of $279.76 Million USD.
Core Laboratories NV Strategic Asset Allocation Index by Year (2000–2025)
Core Laboratories NV strategic asset allocation index by year from 2000 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Core Laboratories NV from 2000 to 2025, covering 25 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Core Laboratories NV (CLB) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 56.6% | $158.22 Million | $153.79 Million | $4.43 Million | $279.76 Million | ▼ -5.0 pp |
| 2024 | 61.5% | $158.63 Million | $153.55 Million | $5.08 Million | $257.74 Million | ▼ -7.3 pp |
| 2023 | 68.9% | $158.31 Million | $153.47 Million | $4.84 Million | $229.81 Million | ▼ -16.8 pp |
| 2022 | 85.7% | $161.86 Million | $157.41 Million | $4.45 Million | $188.95 Million | ▼ -24.0 pp |
| 2021 | 109.6% | $176.50 Million | $172.34 Million | $4.16 Million | $161.00 Million | ▼ -48.4 pp |
| 2020 | 158.0% | $119.39 Million | $115.29 Million | $4.09 Million | $75.57 Million | ▲ +88.0 pp |
| 2019 | 70.0% | $127.47 Million | $123.51 Million | $3.97 Million | $182.14 Million | ▼ -8.7 pp |
| 2018 | 78.7% | $126.68 Million | $122.92 Million | $3.76 Million | $160.90 Million | ▼ -6.4 pp |
| 2017 | 85.2% | $126.66 Million | $123.10 Million | $3.56 Million | $148.73 Million | ▼ -0.6 pp |
| 2016 | 85.7% | $133.11 Million | $129.88 Million | $3.22 Million | $155.30 Million | ▼ -75.3 pp |
| 2014 | 161.0% | $151.35 Million | $149.01 Million | $2.34 Million | $93.99 Million | ▲ +79.1 pp |
| 2013 | 82.0% | $138.82 Million | $138.82 Million | $- | $169.39 Million | ▲ +15.2 pp |
| 2012 | 66.7% | $125.42 Million | $125.42 Million | $- | $187.91 Million | ▲ +3.3 pp |
| 2011 | 63.5% | $115.30 Million | $115.30 Million | $- | $181.66 Million | ▲ +27.8 pp |
| 2010 | 35.7% | $104.22 Million | $104.22 Million | $- | $292.34 Million | ▲ +0.6 pp |
| 2009 | 35.1% | $98.78 Million | $98.78 Million | $- | $281.76 Million | ▼ -29.5 pp |
| 2008 | 64.5% | $103.46 Million | $103.46 Million | $- | $160.31 Million | ▼ -81.7 pp |
| 2007 | 146.2% | $93.04 Million | $93.04 Million | $- | $63.63 Million | ▲ +26.5 pp |
| 2006 | 119.7% | $87.73 Million | $87.73 Million | $- | $73.28 Million | ▲ +81.9 pp |
| 2005 | 37.8% | $81.34 Million | $81.34 Million | $- | $215.32 Million | ▼ -3.8 pp |
| 2004 | 41.6% | $79.62 Million | $79.62 Million | $- | $191.37 Million | ▼ -1.2 pp |
| 2003 | 42.8% | $94.81 Million | $94.81 Million | $- | $221.48 Million | ▲ +5.9 pp |
| 2002 | 36.9% | $95.45 Million | $95.45 Million | $- | $258.49 Million | ▲ +1.6 pp |
| 2001 | 35.3% | $97.61 Million | $97.61 Million | $- | $276.42 Million | ▲ +2.5 pp |
| 2000 | 32.8% | $83.34 Million | $83.34 Million | $- | $253.75 Million | — |